Company Information
Industry 制造业
Company Introduction 吉林敖东药业集团股份有限公司是一家集医药生产、医药销售、医药科研开发为一体的控股型集团公司,经营范围包括医药工业、医药商业、医药科研与开发、种植养殖、商业(国家专项控制、专营除外)等,主导产品有"安神补脑液"、"血府逐瘀口服液"、"利脑心胶囊"、"心脑舒通"、"益血生"等.公司产品多年来一直保持省优、部优和中国中药名牌产品称号,公司的"敖东及图"商标1999年被国家工商总局认定为中国驰名商标.1998年公司被国家经贸委认定为国家级技术中心,2002年公司被农业部等九部委批准为农业产业化国家重点龙头企业。
Main Business 主要从事中药、化学药品研发、制造和销售。
Legal Representative 李秀林
Top Executives
董事长:李秀林
副董事长:郭淑芹
董事:王振宇,张淑媛,赵大龙,杨凯
独立董事:李鹏,肖维维,梁毕明
Top 5 Shareholder
Shareholder name Nature Holding Date
敦化市金诚实业有限责任公司流通A股27.35%08/11/2024
广发证券股份有限公司流通A股3.60%08/11/2024
吉林敖东药业集团股份有限公司-第1期员工持股计划流通A股2.15%08/11/2024
香港中央结算有限公司流通A股1.22%08/11/2024
中国农业银行股份有限公司-中证500交易型开放式指数证券投资基金流通A股1.21%08/11/2024
Company Secretary 王振宇
Solicitors 大连市联合律师事务所
Auditors 中庆会计事务所有限责任公司
Tel No 0433-6238973
Fax No 0433-6238973
Website www.jlaod.com
Email 000623@jlaod.com
Company Address
Register: 吉林省敦化市敖东大街2158号
Office: 吉林省敦化市敖东大街2158号
Listing Date 28/10/1996
Shares Capital
Shares Capital: 1,195,895,387
Total A Share: 1,195,895,387
Listed A Share: 1,191,581,843
Non-tradable A Share: 4,313,544
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.297
DPS(RMB)* ¥ 0.600
NBV Per Share(RMB)* ¥ 22.825
Market Capitalization(RMB) 21.425B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.